Showing 30 of 3541 posts
ANGLE PLC H1 2025: Strong pharma partnerships and tech progress offset by revenue headwinds and funding needs into 2026.
JoshuaSeptember 9, 2025
Onward Opportunities posts record NAV of 129.3p, with 10.4% annual growth and 34.1% outperformance vs AIM since launch.
JoshuaSeptember 8, 2025
ICFG's Mongolian subsidiary SIBJ Group reports 2024 profits of $25m and 81% net profit growth, with loans up 64% CAGR. Strong growth, but check the details.
JoshuaSeptember 8, 2025
Avation PLC expects $110M revenue and cuts $416.8M debt, tackling 2026 notes refinancing in latest trading update.
JoshuaSeptember 8, 2025
Thor Explorations acquires 100% of Douta Gold Project with a capped royalty, boosting control and strategic value ahead of the 2025 PFS.
JoshuaSeptember 8, 2025
The Works reports positive trading, operational upgrades, and confident profit outlook ahead of AGM. LFL sales beat the market.
JoshuaSeptember 8, 2025
Chill Brands partners with SYP Global on groundbreaking nicotine tech: no heating, no solvents, and no cash investment. A low-risk, high-upside strategic play.
JoshuaSeptember 8, 2025
Cerillion's £17.3m follow-on contracts with a major European customer bring the total programme to £25.3m-a strategic win that supports existing market expectations.
JoshuaSeptember 8, 2025
IQE enters formal offer period amid trading challenges, exploring potential sale while navigating weak wireless and defence markets.
JoshuaSeptember 8, 2025
Invinity Energy signs MoU with Chinese giant C&D to scale vanadium flow battery manufacturing in China-a strategic move to meet global demand.
JoshuaSeptember 8, 2025
Phoenix Group's H1 2025 shows strong cash generation, improved solvency, and a higher dividend, despite an IFRS loss due to hedging. Progress on 2026 targets.
JoshuaSeptember 8, 2025
Roquefort Therapeutics' reverse takeover of Coiled USA for £30m pivots to clinical-stage oncology with novel TACC3 inhibitor AO-252.
JoshuaSeptember 8, 2025
Journeo's £5m framework with a UK utility validates its CFDS acquisition and expands its critical infrastructure security footprint over four years.
JoshuaSeptember 8, 2025
Gaming Realms posts 30% EBITDA growth and 18% revenue rise in H1 2025, expanding into new regulated markets including Brazil and Delaware.
JoshuaSeptember 8, 2025
Fiinu's H1 2025 update: white-label bank launch set for Q4, Everfex reverse takeover completed, and balance sheet strengthened via fresh capital raises.
JoshuaSeptember 8, 2025
Trellus Health H1 revenue surges 490% with J&J deal, but cash runway tightens as board explores fundraising.
JoshuaSeptember 8, 2025
Concurrent Technologies reports 26% revenue growth and 25% order intake surge in H1 2025, with strong outlook as US orders expected to rebound.
JoshuaSeptember 8, 2025
Norman Broadbent's record H1 2025 shows 34% NFI growth, 540% EBITDA surge, a return to profit, and a clean net cash position. Turnaround delivered.
JoshuaSeptember 8, 2025
Tissue Regenix reports 6% H1 revenue decline to $13.8m but maintains positive adjusted EBITDA outlook and full-year profitability guidance.
JoshuaSeptember 8, 2025
Camellia PLC reports H1 2025 seasonal loss but outlines Value Enhancement Plan: selling non-core assets, focusing on high-return crops, and shifting to a single annual dividend.
JoshuaSeptember 5, 2025
Chesterfield Resources slashes interim losses through cost discipline and a strategic equity raise, strengthening its balance sheet for future exploration opportunities.
JoshuaSeptember 5, 2025
Peel Hunt expects full-year results to beat market expectations, driven by strong M&A, ECM activity, and execution services. First-half revenues due 1 October 2025.
JoshuaSeptember 5, 2025
Baillie Gifford Shin Nippon underperforms its benchmark in H1 2025, but management changes, share buybacks and a wider investment mandate aim to turn performance around.
JoshuaSeptember 5, 2025
Fadel Partners H1 2025: EBITDA loss narrows 33% as cost cuts offset revenue dip. Full-year guidance unchanged amid stronger H2 optimism.
JoshuaSeptember 5, 2025
Metals One diversifies into graphite with a strategic investment in Evolution Energy Minerals, targeting exposure to the development-ready Chilalo Project in Tanzania.
JoshuaSeptember 5, 2025
essensys returns to adjusted EBITDA profitability in FY25 with £1.3m, launches elumo bookings platform to drive SaaS growth.
JoshuaSeptember 4, 2025
Genus accelerates $160m China JV cash, keeps 49% stake & royalties for PRRS-resistant pigs in world's largest pork market.
JoshuaSeptember 4, 2025
Losses shrink 64% but cash remains tight. Tern PLC's H1 2025 results show progress on costs and new AI/VR bets, with liquidity the key watch-out.
JoshuaSeptember 4, 2025
Alfa Financial Software H1 2025 results: revenue up 20%, profit jumps 33%, and a 5p special dividend declared. Strong growth and cash generation.
JoshuaSeptember 4, 2025
Sherborne Investors NAV drops to 58p as Navient turnaround progresses, with buybacks and cost cuts in focus.
JoshuaSeptember 4, 2025